{
    "organizations": [],
    "uuid": "f854b1e286e6bb719636336ca0aacfd74f4c9524",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-recro-pharma-announces-receipt-of/brief-recro-pharma-announces-receipt-of-issue-notifications-for-three-new-patents-for-iv-meloxicam-idUSFWN1SE0DE",
    "ord_in_thread": 0,
    "title": "Recro Pharma Announces Receipt Of Issue Notifications For Three New Patents For Iv Meloxicam",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Recro Pharma Inc:\n* RECRO PHARMA ANNOUNCES RECEIPT OF ISSUE NOTIFICATIONS FOR THREE NEW PATENTS FOR IV MELOXICAM Source text for Eikon:\nOur ",
    "published": "2018-05-07T19:05:00.000+03:00",
    "crawled": "2018-05-08T16:42:09.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "recro",
        "pharma",
        "inc",
        "recro",
        "pharma",
        "announces",
        "receipt",
        "issue",
        "notification",
        "three",
        "new",
        "patent",
        "iv",
        "meloxicam",
        "source",
        "text",
        "eikon"
    ]
}